Treatment of diabetic ketoacidosis
US4873260A · kind A · utility
4Cited by
1References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 27, 1988 |
| Grant date | Oct 10, 1989 |
| Priority date | — |
| Expiry date | Jun 27, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D305/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
There is disclosed the use of .beta.-lactone alkylene carboxylic acids and derivatives thereof, which are known compounds, for the use of treating diabetic ketoacidosis. The compounds are administered orally or parenterally and compositions containing the .beta.-lactone alkylene carboxylic acid compounds as the active ingredient are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.